Literature DB >> 23846728

Antibiotics a cure for back pain, a false dawn or a new era?

John O'Dowd, Adrian Casey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846728      PMCID: PMC3731499          DOI: 10.1007/s00586-013-2893-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


× No keyword cloud information.
  24 in total

1.  Association between sciatica and Propionibacterium acnes.

Authors:  A Stirling; T Worthington; M Rafiq; P A Lambert; T S Elliott
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

Review 2.  Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain.

Authors:  Tue Secher Jensen; Jaro Karppinen; Joan S Sorensen; Jaakko Niinimäki; Charlotte Leboeuf-Yde
Journal:  Eur Spine J       Date:  2008-09-12       Impact factor: 3.134

Review 3.  Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates.

Authors:  D N Fredricks; D A Relman
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

4.  Antibiotics for back pain: hope or hype?

Authors:  Margaret McCartney
Journal:  BMJ       Date:  2013-05-14

5.  2001 Volvo Award Winner in Clinical Studies: Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group.

Authors:  P Fritzell; O Hägg; P Wessberg; A Nordwall
Journal:  Spine (Phila Pa 1976)       Date:  2001-12-01       Impact factor: 3.468

6.  Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; T R Holford; L Leo-Summers; E F Aldrich; M Fazl; M Fehlings; D L Herr; P W Hitchon; L F Marshall; R P Nockels; V Pascale; P L Perot; J Piepmeier; V K Sonntag; F Wagner; J E Wilberger; H R Winn; W Young
Journal:  JAMA       Date:  1997-05-28       Impact factor: 56.272

7.  Randomized clinical trial of lumbar instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration.

Authors:  Jens Ivar Brox; Roger Sørensen; Astrid Friis; Øystein Nygaard; Aage Indahl; Anne Keller; Tor Ingebrigtsen; Hege R Eriksen; Inger Holm; Anne Kathrine Koller; Rolf Riise; Olav Reikerås
Journal:  Spine (Phila Pa 1976)       Date:  2003-09-01       Impact factor: 3.468

Review 8.  The current role of steroids in acute spinal cord injury.

Authors:  Mohamad Bydon; Joseph Lin; Mohamed Macki; Ziya L Gokaslan; Ali Bydon
Journal:  World Neurosurg       Date:  2013-02-20       Impact factor: 2.104

9.  Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.

Authors:  Mark C Simmonds; Jennifer V E Brown; Morag K Heirs; Julian P T Higgins; Richard J Mannion; Mark A Rodgers; Lesley A Stewart
Journal:  Ann Intern Med       Date:  2013-06-18       Impact factor: 25.391

Review 10.  Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.

Authors:  Rongwei Fu; Shelley Selph; Marian McDonagh; Kimberly Peterson; Arpita Tiwari; Roger Chou; Mark Helfand
Journal:  Ann Intern Med       Date:  2013-06-18       Impact factor: 25.391

View more
  9 in total

Review 1.  The Michel Benoist and Robert Mulholland Yearly European Spine Journal Review: a survey of the "medical" articles in the European Spine Journal, 2013.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2013-12-13       Impact factor: 3.134

Review 2.  The Michel Benoist and Robert Mulholland Yearly European Spine Journal Review: a survey of the "surgical and research" articles in the European Spine Journal, 2013.

Authors:  Robert C Mulholland
Journal:  Eur Spine J       Date:  2014-01-03       Impact factor: 3.134

3.  Modic (endplate) changes in the lumbar spine: bone micro-architecture and remodelling.

Authors:  Egon Perilli; Ian H Parkinson; Le-Hoa Truong; Kuan C Chong; Nicola L Fazzalari; Orso L Osti
Journal:  Eur Spine J       Date:  2014-07-26       Impact factor: 3.134

4.  Evaluation of intervertebral disc regeneration with implantation of bone marrow mesenchymal stem cells (BMSCs) using quantitative T2 mapping: a study in rabbits.

Authors:  Feng Cai; Xiao-Tao Wu; Xin-Hui Xie; Feng Wang; Xin Hong; Su-Yang Zhuang; Lei Zhu; Yun-Feng Rui; Rui Shi
Journal:  Int Orthop       Date:  2014-08-13       Impact factor: 3.075

5.  Ribosomal PCR assay of excised intervertebral discs from patients undergoing single-level primary lumbar microdiscectomy.

Authors:  Todd F Alamin; Marcus Munoz; Alicia Zagel; Agnes Ith; Eugene Carragee; Ivan Cheng; Gaetano Scuderi; Indre Budvytiene; Niaz Banei
Journal:  Eur Spine J       Date:  2017-05-31       Impact factor: 3.134

Review 6.  Overview: the role of Propionibacterium acnes in nonpyogenic intervertebral discs.

Authors:  Zhe Chen; Peng Cao; Zezhu Zhou; Ye Yuan; Yucheng Jiao; Yuehuan Zheng
Journal:  Int Orthop       Date:  2016-01-28       Impact factor: 3.075

Review 7.  Should we start treating chronic low back pain with antibiotics rather than with pain medications?

Authors:  Christof Birkenmaier
Journal:  Korean J Pain       Date:  2013-10-02

8.  Modic Changes and Disc Degeneration Caused by Inoculation of Propionibacterium acnes inside Intervertebral Discs of Rabbits: A Pilot Study.

Authors:  Zhe Chen; Yuehuan Zheng; Ye Yuan; Yucheng Jiao; Jiaqi Xiao; Zezhu Zhou; Peng Cao
Journal:  Biomed Res Int       Date:  2016-01-26       Impact factor: 3.411

9.  Is the discopathy associated with Modic changes an infectious process? Results from a prospective monocenter study.

Authors:  Salim Ahmed-Yahia; Jean-Winoc Decousser; Charles Henri Flouzat-Lachaniette; Guillaume Dervin; François Roubineau; Etienne Audureau; Alexia Hourdille; Guilhem Royer; Florent Eymard; Xavier Chevalier
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.